PhD opportunity with me at @UoL_Biostats, @Richard_D_Riley, Anne Thomas and Samantha Wilkinson at Roche. Model-driven and data-driven solutions for regulatory and HTA decision-making to address emerging challenges in drug development in cancer. Apply here: https://t.co/AxWEo7Y3QU
Lovely to watch @SBujkiewicz in action at the last breakout session of #ISPOREurope 2022: sharing of information in evidence synthesis to strengthen HTA decisions. @UoL_Biostats
@HeatherPoad MSR21: Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship Between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer Monday Poster Session 1; 10:00-13:15
@STEMinist_Coles@STEMinist_Coles not a paper directly on this but this paper has just been published by myself on similar themes https://t.co/NHsgWDJGbL
Thanks @SBujkiewicz for sharing my paper, beat me to tweeting about it! This is my first, first author paper, and the first paper published from my PhD @Cancers_MDPI@UoL_Biostats
Presenting my poster: Exploration of the impact of the treatment mechanism of action on the surrogate relationship between Progression free survival and overall survival in metastatic colorectal cancer, at #ISPOREurope today!
My team and I from @UoL_Biostats are presenting at #ISPOREurope
7 presentations on evidence synthesis: methods and applications – details to follow in the thread
Thanks @SBujkiewicz for sharing my paper, beat me to tweeting about it! This is my first, first author paper, and the first paper published from my PhD @Cancers_MDPI@UoL_Biostats
New paper - congratulations @HeatherPoad on the first paper from your PhD: The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status https://t.co/RlqbRAfCsX #mdpicancers via @Cancers_MDPI
Attending #HTAi2021VirtualAM this week. Last day already! Proud to have my poster "Validity of Surrogate Endpoints in Subgroups of Patients with Advancd Colorectal Cancer Defined by the KRAS Biomarker Status" co-authors @SBujkiewicz@michaelsweeting up in the poster gallery.
Final year UK med student here. Going public with some experiences of a compulsory online exam. Summary: students threatened with disqualification from becoming doctors (in a pandemic) due to problems with online exams (incl. some being forced to urinate in their seats)
This video from @educationgovuk uses the word "SAFE" six times. That is six lots of FALSE REASSURANCE. Negative results from a lateral flow test DO NOT make you safe. Please please please Government, get your heads round this FAST.
I’ve given half my life to medicine.
And medicine wouldn’t give my husband a chest x-ray.
Some kids stole a truck yesterday.
And they almost stole my husband’s life alongside it.
(1)
Have you heard of #BladderCancer? It's time you did - it's the 5th most common cancer in Europe, and it affects all ages 🏵️ Share this post and help spread awareness 🏵️
Be #BladderCancerAware#5thmostcommon
Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study https://t.co/BGPx4DemyU